Clinical Trial Update: Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a two-dose HPV-16/18 immunization schedule in adolescent females has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia
• Human Papillomavirus Infection
• Persistent Hpv Infection

Drugs mentioned

• HPV-16/18 vaccine (Cervarix)

Snippet

Sponsor: Shanghai Zerun Biotechnology Co.,Ltd | Conditions: Human Papillomavirus, Cervical Intraepithelial Neoplasia | Phase 2 | Status: COMPLETED